RegeniTherix™

RegeniTherix™ combines therapeutic (scaffold) and diagnostic (hydrogel capture of biomarkers) technologies.

• Scaffold and hydrogel components are designed to work together to facilitate the collection and sampling of biomarkers produced by the patient’s ingressing cells involved in the wound healing process;
• Resulting in an accurate and minimally invasive method to sample wound biomarkers and gain information on the prospects that a particular wound will heal.
  

RegeniTherix™ ability to detect & quantify prognostic biomarkers was highlighted in a 2023 publication in collaboration with researchers at University of York. Neotherix is delighted that this paper supports the onward development of the product and welcomes any approach from interested partners.

Full Article Available Online: Biosensors and Bioelectronics, Volume 242, 15 December 2023, 115743